SCHEMBL6282689

SCHEMBL6282689

C=CCOC(=O)c1ccccc1-c1ccccc1C(=O)OCC=C

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.82
ALDH1A1 P00352 5/20 0.70
TSHR P16473 4/20 0.70
HSD17B10 Q99714 1/20 0.70
RHOA P61586 1/20 0.55
NPSR1 Q6W5P4 1/20 0.51
LIG1 P18858 1/20 0.45
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
ADRB3 P13945 1/20 0.45
MAPT P10636 3/20 0.44
FGFR1 P11362 1/20 0.44
PKM P14618 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SNCA P37840 1/20 0.43
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5229213 0.93 CYP3A4 (0.72) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL8587092 0.93 CYP3A4 (0.72) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL22231626 0.91 CYP3A4 (0.68) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL16371573 0.90 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL29362146 0.90 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL15174 0.90 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL4072700 0.90 CYP3A4 (0.72) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL11394440 0.89 CYP3A4 (0.96) CYP3A4ALDH1A1TSHRHSD17B10RHOA
Ethylene SCHEMBL11883084 0.89 CYP3A4 (0.96) CYP3A4ALDH1A1TSHRHSD17B10RHOA
SCHEMBL11394446 0.89 CYP3A4 (0.96) CYP3A4ALDH1A1TSHRHSD17B10RHOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939416-B2 Composition for optical stereolithography, stereolithographic object, and method for producing the same OKAMOTO CHEMICAL INDUSTRY CO., LTD. (JP) 2024-03-26 US claimed
JP-4173821-A None JP disclosed
EP-4703794-A1 FLEXOGRAPHIC PRINTING ORIGINAL PLATE, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE Asahi Kasei Kabushiki Kaisha (JP) 2026-03-04 EP disclosed
CN-120192629-A Resin composition 味之素株式会社 2025-06-24 CN disclosed
CN-120059458-A Resin composition 味之素株式会社 2025-05-30 CN disclosed
CN-119432005-A Resin composition 味之素株式会社 2025-02-14 CN disclosed
WO-2024225145-A1 FLEXOGRAPHIC PRINTING ORIGINAL PLATE, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE 旭化成株式会社 2024-10-31 WO disclosed
US-20240254328-A1 RESIN COMPOSITION AJINOMOTO CO., INC. (JP) 2024-08-01 US disclosed
EP-3744740-B1 COMPOSITION FOR OPTICAL THREE-DIMENSIONAL SHAPING, THREE-DIMENSIONAL SHAPED OBJECT, AND PRODUCTION METHOD THEREFOR OKAMOTO CHEMICAL IND CO LTD (JP) 2024-05-15 EP disclosed
US-11939416-B2 Composition for optical stereolithography, stereolithographic object, and method for producing the same OKAMOTO CHEMICAL INDUSTRY CO., LTD. (JP) 2024-03-26 US disclosed
EP-3187515-B1 POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER TOKUYAMA DENTAL CORP (JP) 2020-03-18 EP disclosed
US-20170253555-A1 POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER TOKUYAMA DENTAL CORPORATION (JP) 2017-09-07 US disclosed
EP-3187515-A1 POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER Tokuyama Dental Corporation (JP) 2017-07-05 EP disclosed
CN-105026341-A Methyl-substituted biphenyl compounds, their preparation and their use for producing plasticizers EXXONMOBIL CHEM PATENTS INC 2015-11-04 CN disclosed
US-20130310516-A1 CURABLE COMPOSITION AND CURED MATERIAL OF THE SAME SHOWA DENKO K.K. (JP) 2013-11-21 US disclosed
US-6846900-B2 POLYVALENT CARBOXYLIC ACID ESTER, PROCESS FOR PRODUCING THE CARBOXYLIC ACID ESTER, PLASTIC LENS COMPOSITION USING THE CARBOXYLIC ESTER, PLASTIC LENS OBTAINED BY CURING THE COMPOSITION AND PROCESS FOR PRODUCING THE PLASTIC LENS SHOWA DENKO K.K. (JP) 2005-01-25 US disclosed
US-20030208019-A1 Plastic lens composition, plastic lens, and process for producing the plastic lens SHOWA DENKO K.K. (JP) 2003-11-06 US disclosed
US-20030144447-A1 Novel polyvalent carboxylic acid ester and their use in plastic lens compositions SHOW A DENKO K.K. (JP) 2003-07-31 US disclosed
WO-2002079140-A1 NOVEL POLYVALENT CARBOXYLIC ACID ESTERS AND THEIR USE IN PLASTIC LENS COMPOSITIONS SHOWA DENKO K. K. (JP) 2002-10-10 WO disclosed
JP-H04173821-A ORGANIC GLASS FOR OPTICAL PART ITO KOGAKU KOGYO KK 1992-06-22 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144447-A1 Novel polyvalent carboxylic acid ester and their use in plastic lens compositions VCL, VIM, CRYAA CYP3A4 1715/4885ALDH1A1 1516/4885TSHR 2116/4885
US-20170253555-A1 POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER H1-0, VMP1, CHRM1 CYP3A4 2632/4885ALDH1A1 1350/4885TSHR 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.